196 related articles for article (PubMed ID: 26096149)
1. Reducing progression of experimental lupus nephritis via inhibition of the B7/CD28 signaling pathway.
Huang L; Kong Y; Wang J; Sun J; Shi Q; Qiu YH
Mol Med Rep; 2015 Sep; 12(3):4187-4195. PubMed ID: 26096149
[TBL] [Abstract][Full Text] [Related]
2. A novel monoclonal antibody against human CD80 and its immune protection in a mouse lupus-like disease.
Shi Q; Gao ZY; Xie F; Wang LF; Gu YP; Yang TJ; Huang L; Qian QH; Qiu YH
Int J Immunopathol Pharmacol; 2011; 24(3):583-93. PubMed ID: 21978690
[TBL] [Abstract][Full Text] [Related]
3. Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28.
Laurent L; Le Fur A; Bloas RL; Néel M; Mary C; Moreau A; Poirier N; Vanhove B; Fakhouri F
Eur J Immunol; 2017 Aug; 47(8):1368-1376. PubMed ID: 28631301
[TBL] [Abstract][Full Text] [Related]
4. Control of mouse graft-versus-host disease following allogeneic bone marrow transplantation by blocking the CD28/B7 signaling pathway with lentiviral vector-mediated RNA interference.
Sang W; Zhou C; Cheng N; Li Z; Zeng L; Xu K
Immunol Lett; 2011 May; 136(2):194-202. PubMed ID: 21277900
[TBL] [Abstract][Full Text] [Related]
5. A novel monoclonal antibody against human B7-1 protects against chronic graft-vs.-host disease in a murine lupus nephritis model.
Shen L; Zhu Y; Han L; Wang Y; Yan T; Kong Y; Zou S; Qiu Y; Xu Y
Exp Ther Med; 2020 Nov; 20(5):14. PubMed ID: 32934679
[TBL] [Abstract][Full Text] [Related]
6. Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice.
Xiang L; Liu A; Xu G
Am J Physiol Renal Physiol; 2020 May; 318(5):F1258-F1270. PubMed ID: 32249615
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody against CD86 and its protection in a murine lupus nephritis model of chronic graft-versus-host disease.
Han L; Shen L; Zhu Y; Qiu Y
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):285-291. PubMed ID: 28747139
[TBL] [Abstract][Full Text] [Related]
8. Nephritogenic autoantibodies but absence of nephritis in Il-12p35-deficient mice with pristane-induced lupus.
Calvani N; Satoh M; Croker BP; Reeves WH; Richards HB
Kidney Int; 2003 Sep; 64(3):897-905. PubMed ID: 12911539
[TBL] [Abstract][Full Text] [Related]
9. Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands
Liang CL; Jiang H; Feng W; Liu H; Han L; Chen Y; Zhang Q; Zheng F; Lu CJ; Dai Z
Front Immunol; 2021; 12():683249. PubMed ID: 34290705
[TBL] [Abstract][Full Text] [Related]
10. Interferon-gamma is required for lupus nephritis in mice treated with the hydrocarbon oil pristane.
Richards HB; Satoh M; Jennette JC; Croker BP; Yoshida H; Reeves WH
Kidney Int; 2001 Dec; 60(6):2173-80. PubMed ID: 11737591
[TBL] [Abstract][Full Text] [Related]
11. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
Sun J; Guo S; Niu F; Liu D; Zhuang Y
Mol Med Rep; 2020 Dec; 22(6):5436-5443. PubMed ID: 33173997
[TBL] [Abstract][Full Text] [Related]
12. Targeted IgA Fc receptor I (FcαRI) therapy in the early intervention and treatment of pristane-induced lupus nephritis in mice.
Liu C; Kanamaru Y; Watanabe T; Tada N; Horikoshi S; Suzuki Y; Liu Z; Tomino Y
Clin Exp Immunol; 2015 Sep; 181(3):407-16. PubMed ID: 25907714
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor prevents lupus nephritis in a murine lupus model of chronic graft-versus-host disease.
Kuroiwa T; Iwasaki T; Imado T; Sekiguchi M; Fujimoto J; Sano H
Arthritis Res Ther; 2006; 8(4):R123. PubMed ID: 16859527
[TBL] [Abstract][Full Text] [Related]
14. IK cytokine ameliorates the progression of lupus nephritis in MRL/lpr mice.
Muraoka M; Hasegawa H; Kohno M; Inoue A; Miyazaki T; Terada M; Nose M; Yasukawa M
Arthritis Rheum; 2006 Nov; 54(11):3591-600. PubMed ID: 17075801
[TBL] [Abstract][Full Text] [Related]
15. α-mangostin attenuates pristane-induced lupus nephritis by regulating Th17 differentiation.
Zhou X; Chen H; Wei F; Zhao Q; Su Q; Lei Y; Yin M; Tian X; Liu Z; Yu B; Bai C; He X; Huang Z
Int J Rheum Dis; 2020 Jan; 23(1):74-83. PubMed ID: 31769201
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
[TBL] [Abstract][Full Text] [Related]
17. Histamine 4 receptor promotes expression of costimulatory B7.1/B7.2 molecules, CD28 signaling and cytokine production in stress-induced immune responses.
Ahmad SF; Zoheir KM; Ansari MA; Nadeem A; Bakheet SA; Al-Hoshani AR; Al-Shabanah OA; Al-Harbi MM; Attia SM
J Neuroimmunol; 2015 Dec; 289():30-42. PubMed ID: 26616869
[TBL] [Abstract][Full Text] [Related]
18. Requirement of Toll-like receptor 7 for pristane-induced production of autoantibodies and development of murine lupus nephritis.
Savarese E; Steinberg C; Pawar RD; Reindl W; Akira S; Anders HJ; Krug A
Arthritis Rheum; 2008 Apr; 58(4):1107-15. PubMed ID: 18383384
[TBL] [Abstract][Full Text] [Related]
19. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
Renner K; Hermann FJ; Schmidbauer K; Talke Y; Rodriguez Gomez M; Schiechl G; Schlossmann J; Brühl H; Anders HJ; Mack M
Kidney Int; 2015 Nov; 88(5):1088-98. PubMed ID: 26131743
[TBL] [Abstract][Full Text] [Related]
20. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
Hasegawa H; Kohno M; Sasaki M; Inoue A; Ito MR; Terada M; Hieshima K; Maruyama H; Miyazaki J; Yoshie O; Nose M; Fujita S
Arthritis Rheum; 2003 Sep; 48(9):2555-66. PubMed ID: 13130475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
